Cisen Pharmaceutical Co., Ltd. (hereinafter referred to as “Cisen Pharmaceutical”) is a comprehensive chemicals manufacturing enterprise in China. It is a joint-equity enterprise, governing three main wholly-owned subsidiaries including Shandong Chenlong Pharmaceutical Co., Ltd., Cisen Fodu Pharmaceutical (Wenshang) Co., Ltd., and Beijing Cisen Huizhi Medicine Science & Technology Co., Ltd., as well as some other joint-stock subsidiaries. The company’s predecessor is Jining City No.3 Pharmaceutical Factory, which was restructured as Shandong Lukang Cisen Pharmaceutical Co., Ltd. in 1998, and then officially renamed as Cisen Pharmaceutical Co., Ltd. in 2011.

　　 At present, the company is a National-recognized Enterprise Technology Center, the Vice-President Unit of China Pharmaceutical Industry Association, one of the Top 100 Pharmaceutical Industry Enterprises in China, a national-level new high-tech enterprise, and the National Enterprise of Keeping Promise & Honoring Contracts. It owns a post-doctoral research workstation and the Shandong Taishan Scholar posts for specially hired specialist on medicines, as well as Shandong Province Antibiotics Engineering Research Center and Shandong Province Intravenous Nutrition Large-volume Injection Engineering Laboratory. The company covers an area of more than 2000 mu, has approximate 4000 employees where the professional technicians above 1000, and possesses the total assets of 2.9 billion yuan.